Condition
Ketones
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06327464Not ApplicableCompleted
Exogenous Ketones and Appetite
NCT07527156Phase 4Recruiting
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
NCT07186660Phase 2Recruiting
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
NCT03461068Phase 1CompletedPrimary
Exogenous Ketones and Glucose Tolerance
NCT02825823Not ApplicableCompleted
The Effects of Exogenous Ketones on Exercise Performance in Young Healthy Adults
Showing all 5 trials